Pilot Study on Immunotherapy for the Treatment of Persistant Peanut Allergy
Status:
Recruiting
Trial end date:
2022-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this trial is to assess the safety and efficacy of peanut immunotherapy in
children and adults with peanut allergy. Participants will receive immunotherapy with peanut
every 2 weeks for a period of 3 months.